FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

377279002: Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3699509018 Chlorothiazide 250 mg and reserpine 125 microgram oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3699510011 Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
108313301000001113 Chlorothiazide 250 mg and reserpine 0.125 mg oral tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Is a Product containing reserpine false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Is a Product containing chlorothiazide false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient Reserpine - chemical false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient Chlorothiazide false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Is a Product containing chlorothiazide and reserpine false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient Reserpine false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient Centrally acting hypotensive agent false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Is a Product containing chlorothiazide in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has basis of strength substance Reserpine false Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has basis of strength substance Chlorothiazide false Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength numerator value 250 false Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient Chlorothiazide false Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has basis of strength substance Chlorothiazide true Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength numerator value 250 false Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has active ingredient Reserpine false Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has basis of strength substance Reserpine true Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength numerator value 0.125 false Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has precise active ingredient Chlorothiazide false Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Is a Product containing chlorothiazide and reserpine in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has precise active ingredient Reserpine false Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength numerator value 125 false Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength numerator unit microgram false Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Is a Product containing only chlorothiazide and reserpine in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Plays role Diuretic therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength numerator unit microgram true Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has precise active ingredient Chlorothiazide true Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has precise active ingredient Reserpine true Inferred relationship Existential restriction modifier 2
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start